title: Expression of vitamin D receptor (VDR), cyclooxygenase-2 (COX-2) and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in benign and malignant ovarian tissue and 25-hydroxycholecalciferol (25(OH2)D3) and prostaglandin E2 (PGE2) serum level in ovarian cancer patients.
authors.affiliation: Department of Obstetrics and Gynecology, University Hospital Schleswig-Holstein, Campus Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany. marc.thill@uk-sh.de
authors.forename: Marc
authors.initials: M
authors.lastname: Thill
authors.forename: Dorothea
authors.initials: D
authors.lastname: Fischer
authors.forename: Katharina
authors.initials: K
authors.lastname: Kelling
authors.forename: Friederike
authors.initials: F
authors.lastname: Hoellen
authors.forename: Christine
authors.initials: C
authors.lastname: Dittmer
authors.forename: Amadeus
authors.initials: A
authors.lastname: Hornemann
authors.forename: Darius
authors.initials: D
authors.lastname: Salehin
authors.forename: Klaus
authors.initials: K
authors.lastname: Diedrich
authors.forename: Michael
authors.initials: M
authors.lastname: Friedrich
authors.forename: Steffi
authors.initials: S
authors.lastname: Becker
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002112:Calcifediol / Q000378:metabolism*; D051546:Cyclooxygenase 2 / Q000096:biosynthesis*; D015232:Dinoprostone / Q000378:metabolism*; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D006911:Hydroxyprostaglandin Dehydrogenases / Q000096:biosynthesis*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000201:enzymology* / Q000378:metabolism*; D010053:Ovary / Q000201:enzymology* / Q000378:metabolism*; D018167:Receptors, Calcitriol / Q000096:biosynthesis*
chemical_list: D018167:Receptors, Calcitriol; D006911:Hydroxyprostaglandin Dehydrogenases; C035859:15-hydroxyprostaglandin dehydrogenase; D051546:Cyclooxygenase 2; D015232:Dinoprostone; D002112:Calcifediol